{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:56:18Z","timestamp":1793652978160,"version":"4.5.1"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017618","name":"Division of Diabetes, Endocrinology, and Metabolic Diseases","doi-asserted-by":"publisher","award":["5K23DK131342"],"award-info":[{"award-number":["5K23DK131342"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00125-025-06494-4","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:28:33Z","timestamp":1753198113000},"page":"2430-2448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Disparities in access to and use of diabetes technologies and therapeutics: a narrative review"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0508-4309","authenticated-orcid":false,"given":"Ananta","family":"Addala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mcking I.","family":"Amedari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-3239","authenticated-orcid":false,"given":"Lauren E.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8473-249X","authenticated-orcid":false,"given":"Osagie","family":"Ebekozien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"7","key":"6494_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/pedi.12711","volume":"19","author":"DJ DeSalvo","year":"2018","unstructured":"DeSalvo DJ, Miller KM, Hermann JM et al (2018) Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: international comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes 19(7):1271\u20131275. https:\/\/doi.org\/10.1111\/pedi.12711","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"6494_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","volume":"21","author":"NC Foster","year":"2019","unstructured":"Foster NC, Beck RW, Miller KM et al (2019) State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018. Diabetes Technol Ther 21(2):66\u201372. https:\/\/doi.org\/10.1089\/dia.2018.0384","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"6494_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2337\/dc19-1214","volume":"43","author":"KM Miller","year":"2020","unstructured":"Miller KM, Hermann J, Foster N et al (2020) Longitudinal changes in continuous glucose monitoring use among individuals with type 1 diabetes: international comparison in the German and Austrian DPV and U.S. T1D exchange registries. Dia Care 43(1):e1\u2013e2. https:\/\/doi.org\/10.2337\/dc19-1214","journal-title":"Dia Care"},{"issue":"23","key":"6494_CR4","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.2020.6940","volume":"323","author":"LM Laffel","year":"2020","unstructured":"Laffel LM, Kanapka LG, Beck RW et al (2020) Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. JAMA 323(23):2388\u20132396. https:\/\/doi.org\/10.1001\/jama.2020.6940","journal-title":"JAMA"},{"issue":"12","key":"6494_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/dia.2021.0153","volume":"23","author":"KK Hood","year":"2021","unstructured":"Hood KK, Laffel LM, Danne T et al (2021) Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. Diabetes Technol Ther 23(12):857\u2013861. https:\/\/doi.org\/10.1089\/dia.2021.0153","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"6494_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","volume":"67","author":"M Jancev","year":"2024","unstructured":"Jancev M, Vissers TACM, Visseren FLJ et al (2024) Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia 67(5):798\u2013810. https:\/\/doi.org\/10.1007\/s00125-024-06107-6","journal-title":"Diabetologia"},{"issue":"5","key":"6494_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2337\/dc19-1459","volume":"43","author":"MI Maiorino","year":"2020","unstructured":"Maiorino MI, Signoriello S, Maio A et al (2020) Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care 43(5):1146\u20131156. https:\/\/doi.org\/10.2337\/dc19-1459","journal-title":"Diabetes Care"},{"issue":"12","key":"6494_CR8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/dc23-0504","volume":"46","author":"B Zeng","year":"2023","unstructured":"Zeng B, Gao L, Yang Q, Jia H, Sun F (2023) Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomized controlled trials. Diabetes Care 46(12):2300\u20132307. https:\/\/doi.org\/10.2337\/dc23-0504","journal-title":"Diabetes Care"},{"issue":"7","key":"6494_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold KC, Bundy BN, Long SA et al (2019) An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 381(7):603\u2013613. https:\/\/doi.org\/10.1056\/NEJMoa1902226","journal-title":"N Engl J Med"},{"issue":"23","key":"6494_CR10","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","volume":"389","author":"EL Ramos","year":"2023","unstructured":"Ramos EL, Dayan CM, Chatenoud L et al (2023) Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes. N Engl J Med 389(23):2151\u20132161. https:\/\/doi.org\/10.1056\/NEJMoa2308743","journal-title":"N Engl J Med"},{"issue":"1","key":"6494_CR11","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2337\/dc24-S008","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","unstructured":"American Diabetes Association Professional Practice Committee (2023) 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes\u20132024. Diabetes Care 47(1):S145\u2013S157. https:\/\/doi.org\/10.2337\/dc24-S008","journal-title":"Diabetes Care"},{"issue":"1","key":"6494_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2337\/dc20-0257","volume":"44","author":"A Addala","year":"2021","unstructured":"Addala A, Auzanneau M, Miller K et al (2021) A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care 44(1):133\u2013140. https:\/\/doi.org\/10.2337\/dc20-0257","journal-title":"Diabetes Care"},{"issue":"8","key":"6494_CR13","doi-asserted-by":"publisher","first-page":"e2960","DOI":"10.1210\/clinem\/dgaa236","volume":"105","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Kanapka LG, Raymond JK et al (2020) Racial-ethnic inequity in young adults with type 1 diabetes. J Clin Endocrinol Metab 105(8):e2960\u2013e2969. https:\/\/doi.org\/10.1210\/clinem\/dgaa236","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6494_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1542\/peds.2014-1774","volume":"135","author":"SM Willi","year":"2015","unstructured":"Willi SM, Miller KM, DiMeglio LA et al (2015) Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. PEDIATRICS 135(3):424\u2013434. https:\/\/doi.org\/10.1542\/peds.2014-1774","journal-title":"PEDIATRICS"},{"issue":"11","key":"6494_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/dia.2023.0320","volume":"25","author":"O Ebekozien","year":"2023","unstructured":"Ebekozien O, Mungmode A, Sanchez J et al (2023) Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016\u20132022) from the T1D exchange quality improvement collaborative. Diabetes Technol Ther 25(11):765\u2013773. https:\/\/doi.org\/10.1089\/dia.2023.0320","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"6494_CR16","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.2337\/dci23-0057","volume":"46","author":"A Addala","year":"2023","unstructured":"Addala A (2023) Making a good thing even better: expanding access and applicability of automated insulin delivery systems to benefit all youth with type 1 diabetes. Diabetes Care 46(12):2126\u20132128. https:\/\/doi.org\/10.2337\/dci23-0057","journal-title":"Diabetes Care"},{"issue":"8","key":"6494_CR17","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2337\/dc23-0560","volume":"46","author":"TODAY Study Group","year":"2023","unstructured":"TODAY Study Group (2023) Effect of early glycemic control in youth-onset type 2 diabetes on longer-term glycemic control and \u03b2-Cell function: results from the TODAY study. Diabetes Care 46(8):1507\u20131514. https:\/\/doi.org\/10.2337\/dc23-0560","journal-title":"Diabetes Care"},{"issue":"24","key":"6494_CR18","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","volume":"366","author":"TODAY Study Group","year":"2012","unstructured":"TODAY Study Group (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366(24):2247\u20132256. https:\/\/doi.org\/10.1056\/NEJMoa1109333","journal-title":"N Engl J Med"},{"issue":"5","key":"6494_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa2100165","volume":"385","author":"TODAY Study Group","year":"2021","unstructured":"TODAY Study Group (2021) Long-term complications in youth-onset type 2 diabetes. N Engl J Med 385(5):416\u2013426. https:\/\/doi.org\/10.1056\/NEJMoa2100165","journal-title":"N Engl J Med"},{"issue":"3","key":"6494_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/dia.2022.0387","volume":"25","author":"M Salam","year":"2023","unstructured":"Salam M, Bailey R, Calhoun P et al (2023) A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. Diabetes Technol Ther 25(3):178\u2013185. https:\/\/doi.org\/10.1089\/dia.2022.0387","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"6494_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev.publhealth.24.100901.140816","volume":"24","author":"PH Wise","year":"2003","unstructured":"Wise PH (2003) The anatomy of a disparity in infant mortality. Annu Rev Public Health 24(1):341\u2013362. https:\/\/doi.org\/10.1146\/annurev.publhealth.24.100901.140816","journal-title":"Annu Rev Public Health"},{"issue":"7243","key":"6494_CR22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/bmj.320.7243.1200","volume":"320","author":"JW Lynch","year":"2000","unstructured":"Lynch JW, Smith GD, Kaplan GA, House JS (2000) Income inequality and mortality: importance to health of individual income, psychosocial environment, or material conditions. BMJ 320(7243):1200\u20131204","journal-title":"BMJ"},{"issue":"1","key":"6494_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2021","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA et al (2021) Social determinants of health and diabetes: a scientific review. Dia Care 44(1):258\u2013279. https:\/\/doi.org\/10.2337\/dci20-0053","journal-title":"Dia Care"},{"issue":"2","key":"6494_CR24","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","volume":"104","author":"S George","year":"2014","unstructured":"George S, Duran N, Norris K (2014) A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific islanders. Am J Public Health 104(2):e16\u2013e31. https:\/\/doi.org\/10.2105\/AJPH.2013.301706","journal-title":"Am J Public Health"},{"issue":"3","key":"6494_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1748-720X.2008.299.x","volume":"36","author":"SL Smith","year":"2008","unstructured":"Smith SL (2008) Mustard gas and American race-based human experimentation in world war II. J Law Med Ethics 36(3):517\u2013521. https:\/\/doi.org\/10.1111\/j.1748-720X.2008.299.x","journal-title":"J Law Med Ethics"},{"key":"6494_CR26","volume-title":"Bad blood: the Tuskegee syphilis experiment","author":"JH Jones","year":"1981","unstructured":"Jones JH (1981) Bad blood: the Tuskegee syphilis experiment. Free Press, New York, NY, USA"},{"key":"6494_CR27","volume-title":"Research ethics","author":"JM Barrow","year":"2025","unstructured":"Barrow JM, Brannan GD, Khandhar PB (2025) Research ethics. StatPearls Publishing, Treasure Island, FL, USA"},{"key":"6494_CR28","doi-asserted-by":"publisher","first-page":"b613","DOI":"10.1136\/bmj.b613","volume":"338","author":"KM Venables","year":"2009","unstructured":"Venables KM, Brooks C, Linsell L et al (2009) Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study. BMJ 338:b613. https:\/\/doi.org\/10.1136\/bmj.b613","journal-title":"BMJ"},{"issue":"1","key":"6494_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/annhyg\/men040","volume":"53","author":"TJ Keegan","year":"2009","unstructured":"Keegan TJ, Walker SAS, Brooks C et al (2009) Exposures recorded for participants in the UK chemical warfare agent human research programme, 1941\u20131989. Ann Occup Hyg 53(1):83\u201397. https:\/\/doi.org\/10.1093\/annhyg\/men040","journal-title":"Ann Occup Hyg"},{"key":"6494_CR30","unstructured":"Hunt S, Riegelman A, Myers-Kelley S (2024) Research Guides: Conducting research through an anti-racism lens. Available from: https:\/\/libguides.umn.edu\/c.php?g=1096139&p=7993780. Accessed 25 Nov 2024"},{"issue":"7","key":"6494_CR31","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.2337\/dc20-2753","volume":"44","author":"AF Walker","year":"2021","unstructured":"Walker AF, Hood KK, Gurka MJ et al (2021) Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes. Diabetes Care 44(7):1480\u20131490. https:\/\/doi.org\/10.2337\/dc20-2753","journal-title":"Diabetes Care"},{"key":"6494_CR32","doi-asserted-by":"publisher","unstructured":"Agarwal S, Crespo-Ramos G, Long JA, Miller VA (2021) \u201cI didn\u2019t really have a choice\u201d: qualitative analysis of racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther 23(9). https:\/\/doi.org\/10.1089\/dia.2021.0075","DOI":"10.1089\/dia.2021.0075"},{"key":"6494_CR33","doi-asserted-by":"publisher","unstructured":"Medina Pe\u00f1aranda R, Figg LE, Hanes SJ et al (2024) Strategies for equitable recruitment to engage underrepresented youth and their families into clinical research: findings from the BEAD-T1D pilot study. Horm Res Paediatr 1\u20139. https:\/\/doi.org\/10.1159\/000541774","DOI":"10.1159\/000541774"},{"issue":"8","key":"6494_CR34","doi-asserted-by":"publisher","first-page":"e072546","DOI":"10.1136\/bmjopen-2023-072546","volume":"13","author":"A Addala","year":"2023","unstructured":"Addala A, Hechavarria M, Figg L et al (2023) Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA. BMJ Open 13(8):e072546. https:\/\/doi.org\/10.1136\/bmjopen-2023-072546","journal-title":"BMJ Open"},{"issue":"1","key":"6494_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/heq.2020.0038","volume":"4","author":"EA Brown","year":"2020","unstructured":"Brown EA, White BM (2020) Recognizing privilege as a social determinant of health during COVID-19. Health Equity 4(1):1\u20134. https:\/\/doi.org\/10.1089\/heq.2020.0038","journal-title":"Health Equity"},{"issue":"7","key":"6494_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/pedi.13082","volume":"21","author":"A Addala","year":"2020","unstructured":"Addala A, Maahs DM, Scheinker D, Chertow S, Leverenz B, Prahalad P (2020) Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance. Pediatric Diabetes 21(7):1301\u20131309. https:\/\/doi.org\/10.1111\/pedi.13082","journal-title":"Pediatric Diabetes"},{"issue":"1","key":"6494_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.0006-341X.2005.031040.x.Accessed11Aug2022","volume":"61","author":"T Vangeneugden","year":"2005","unstructured":"Vangeneugden T, Laenen A, Geys H, Renard D, Molenberghs G (2005) Applying concepts of generalizability theory on clinical trial data to investigate sources of variation and their impact on reliability. Biometrics 61(1):295\u2013304. https:\/\/doi.org\/10.1111\/j.0006-341X.2005.031040.x.Accessed11Aug2022","journal-title":"Biometrics"},{"issue":"1","key":"6494_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2337\/dc09-1502","volume":"33","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2010","unstructured":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care 33(1):17\u201322. https:\/\/doi.org\/10.2337\/dc09-1502","journal-title":"Diabetes Care"},{"issue":"3","key":"6494_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/dia.2019.0303","volume":"22","author":"JE Anderson","year":"2020","unstructured":"Anderson JE, Gavin JR, Kruger DF (2020) Current eligibility requirements for CGM coverage are harmful, costly, and unjustified. Diabetes Technol Ther 22(3):169\u2013173. https:\/\/doi.org\/10.1089\/dia.2019.0303","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"6494_CR40","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.2337\/dc20-3063","volume":"44","author":"HK Akturk","year":"2021","unstructured":"Akturk HK, Agarwal S, Hoffecker L, Shah VN (2021) Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: critical need for new standards. Diabetes Care 44(6):e121\u2013e123. https:\/\/doi.org\/10.2337\/dc20-3063","journal-title":"Diabetes Care"},{"issue":"18","key":"6494_CR41","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1907863","journal-title":"N Engl J Med"},{"issue":"10","key":"6494_CR42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1089\/dia.2023.0197","volume":"25","author":"J Garc\u00eda-Tirado","year":"2023","unstructured":"Garc\u00eda-Tirado J, Villard O, Hall M, Bisio A, Gonder-Frederick L (2023) Under-representation of diverse populations and glycemic outcomes in major clinical trials of automated insulin delivery. Diabetes Technol Ther 25(10):752\u2013754. https:\/\/doi.org\/10.1089\/dia.2023.0197","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"6494_CR43","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2337\/dc20-0389","volume":"44","author":"ET Jensen","year":"2021","unstructured":"Jensen ET, Stafford JM, Saydah S et al (2021) Increase in prevalence of diabetic ketoacidosis at diagnosis among youth with type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Care 44(7):1573\u20131578. https:\/\/doi.org\/10.2337\/dc20-0389","journal-title":"Diabetes Care"},{"issue":"12","key":"6494_CR44","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.2337\/dc19-0593","volume":"42","author":"EK Sims","year":"2019","unstructured":"Sims EK, Geyer S, Johnson SB et al (2019) Who is enrolling? the path to monitoring in type 1 diabetes TrialNet\u2019s pathway to prevention. Diabetes Care 42(12):2228\u20132236. https:\/\/doi.org\/10.2337\/dc19-0593","journal-title":"Diabetes Care"},{"issue":"24","key":"6494_CR45","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2019.19365","volume":"322","author":"YJ Cheng","year":"2019","unstructured":"Cheng YJ, Kanaya AM, Araneta MRG et al (2019) Prevalence of diabetes by race and ethnicity in the United States, 2011\u20132016. JAMA 322(24):2389\u20132398. https:\/\/doi.org\/10.1001\/jama.2019.19365","journal-title":"JAMA"},{"key":"6494_CR46","doi-asserted-by":"publisher","unstructured":"Husain M, Birkenfeld AL, PIONEER 6 Investigators\u00a0\u00a0et al\u00a0(2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 381(9):841\u2013851. https:\/\/doi.org\/10.1056\/NEJMoa1901118","DOI":"10.1056\/NEJMoa1901118"},{"key":"6494_CR47","doi-asserted-by":"publisher","unstructured":"Agarwal S, Crespo-Ramos G, Leung SL et al (2022) Solutions to address inequity in diabetes technology use in type 1 diabetes: results from multidisciplinary stakeholder co-creation workshops. Diabetes Technol Ther 24(6). https:\/\/doi.org\/10.1089\/dia.2021.0496","DOI":"10.1089\/dia.2021.0496"},{"key":"6494_CR48","unstructured":"Federal Register (2024) Revisions to OMB\u2019s Statistical Policy Directive No. 15: Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity. Available from: https:\/\/www.federalregister.gov\/documents\/2024\/03\/29\/2024-06469\/revisions-to-ombs-statistical-policy-directive-no-15-standards-for-maintaining-collecting-and. Accessed 7 Dec 2024"},{"key":"6494_CR49","unstructured":"National Institutes of Health (NIH) (2022) Race and National Origin. Available from: https:\/\/www.nih.gov\/nih-style-guide\/race-national-origin. Accessed 7 Dec 2024"},{"key":"6494_CR50","doi-asserted-by":"publisher","first-page":"111568","DOI":"10.1016\/j.diabres.2024.111568","volume":"209","author":"A Addala","year":"2024","unstructured":"Addala A, Penaranda RM, Naranjo D, Maahs DM, Hood KK (2024) Intersectional identities play a role in perceived discrimination for families living with type 1 diabetes. Diabetes Res Clin Pract 209:111568. https:\/\/doi.org\/10.1016\/j.diabres.2024.111568","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"6494_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1037\/fsh0000859","volume":"41","author":"DN Motley","year":"2023","unstructured":"Motley DN, Victorian J, Denis K, Brooks BD (2023) Applying an intersectionality framework to health services research. Fam Syst Health 41(4):417\u2013424. https:\/\/doi.org\/10.1037\/fsh0000859","journal-title":"Fam Syst Health"},{"issue":"1","key":"6494_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12889-021-12428-7","volume":"22","author":"GI Mielke","year":"2022","unstructured":"Mielke GI, Malta DC, Nunes BP, Cairney J (2022) All are equal, but some are more equal than others: social determinants of leisure time physical activity through the lens of intersectionality. BMC Public Health 22(1):36. https:\/\/doi.org\/10.1186\/s12889-021-12428-7","journal-title":"BMC Public Health"},{"key":"6494_CR53","doi-asserted-by":"publisher","unstructured":"Cherrington AL, Krause-Steinrauf H, Aroda V et al (2023) Use of comprehensive recruitment strategies in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE) multi-center clinical trial. Clin Trials 20(5). https:\/\/doi.org\/10.1177\/17407745231175919","DOI":"10.1177\/17407745231175919"},{"issue":"1","key":"6494_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2337\/cd22-0072","volume":"41","author":"A Mungmode","year":"2022","unstructured":"Mungmode A, Noor N, Weinstock RS et al (2022) Making diabetes electronic medical record data actionable: promoting benchmarking and population health improvement using the T1D exchange quality improvement portal. Clin Diabetes 41(1):45\u201355. https:\/\/doi.org\/10.2337\/cd22-0072","journal-title":"Clin Diabetes"},{"issue":"3","key":"6494_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2337\/dsi22-0002","volume":"35","author":"O Ebekozien","year":"2022","unstructured":"Ebekozien O, Mungmode A, Buckingham D et al (2022) Achieving equity in diabetes research: borrowing from the field of quality improvement using a practical framework and improvement tools. Diabetes Spectrum 35(3):304\u2013312","journal-title":"Diabetes Spectrum"},{"issue":"5","key":"6494_CR56","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.acap.2022.10.003","volume":"23","author":"L Yemane","year":"2023","unstructured":"Yemane L, Ramirez M, Guerin A et al (2023) Sparking a movement, not a moment: framework and outcomes from a pediatrics department-wide coalition to advance anti-racism. Acad Pediatr 23(5):886\u2013892. https:\/\/doi.org\/10.1016\/j.acap.2022.10.003","journal-title":"Acad Pediatr"},{"issue":"4","key":"6494_CR57","doi-asserted-by":"publisher","first-page":"e1909","DOI":"10.1210\/clinem\/dgaa938","volume":"106","author":"SH Golden","year":"2021","unstructured":"Golden SH, Joseph JJ, Hill-Briggs F (2021) Casting a health equity lens on endocrinology and diabetes. J Clin Endocrinol Metab 106(4):e1909\u2013e1916. https:\/\/doi.org\/10.1210\/clinem\/dgaa938","journal-title":"J Clin Endocrinol Metab"},{"key":"6494_CR58","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1056\/NEJMp2005835","volume":"382","author":"S Keesara","year":"2020","unstructured":"Keesara S, Jonas A, Schulman K (2020) Covid-19 and health care\u2019s digital revolution. N Engl J Med 382:e82. https:\/\/doi.org\/10.1056\/NEJMp2005835","journal-title":"N Engl J Med"},{"issue":"5","key":"6494_CR59","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11606-021-07304-4","volume":"37","author":"OE Adepoju","year":"2022","unstructured":"Adepoju OE, Chae M, Ojinnaka CO, Shetty S, Angelocci T (2022) Utilization gaps during the COVID-19 pandemic: racial and ethnic disparities in telemedicine uptake in federally qualified health center clinics. J Gen Intern Med 37(5):1191\u20131197. https:\/\/doi.org\/10.1007\/s11606-021-07304-4","journal-title":"J Gen Intern Med"},{"key":"6494_CR60","doi-asserted-by":"publisher","unstructured":"Baidal JW, Wang AY, Zumwalt K et al (2020) Social determinants of health and COVID-19 among patients in New York City. Res Sq rs.3.rs-70959 (Preprint). 15 Sep 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-70959\/v1","DOI":"10.21203\/rs.3.rs-70959\/v1"},{"issue":"6","key":"6494_CR61","doi-asserted-by":"publisher","first-page":"e2321281","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D\u2019Souza","year":"2023","unstructured":"D\u2019Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R (2023) Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Netw Open 6(6):e2321281. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.21281","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"6494_CR62","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.2337\/dc24-S014","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee (2024) 14. Children and adolescents: standards of care in diabetes-2024. Diabetes Care 47(Suppl 1):S258\u2013S281. https:\/\/doi.org\/10.2337\/dc24-S014","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"6494_CR63","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.2337\/dc24-S007","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee (2024) 7. Diabetes technology: standards of care in diabetes\u20142024. Diabetes Care 47(Suppl 1):S126\u2013S144. https:\/\/doi.org\/10.2337\/dc24-S007","journal-title":"Diabetes Care"},{"key":"6494_CR64","doi-asserted-by":"publisher","DOI":"10.1377\/forefront.20230714.676093","author":"WR Powell","year":"2023","unstructured":"Powell WR, Sheehy AM, Kind AJH (2023) The area deprivation index is the most scientifically validated social exposome tool available for policies advancing health equity. Health Affairs Forefront. https:\/\/doi.org\/10.1377\/forefront.20230714.676093","journal-title":"Health Affairs Forefront"},{"issue":"12","key":"6494_CR65","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2337\/dc18-0724","volume":"41","author":"M Auzanneau","year":"2018","unstructured":"Auzanneau M, Lanzinger S, Bohn B et al (2018) Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: a cross-sectional multicenter DPV analysis. Dia Care 41(12):2517\u20132525. https:\/\/doi.org\/10.2337\/dc18-0724","journal-title":"Dia Care"},{"issue":"5","key":"6494_CR66","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1177\/19322968211028608","volume":"15","author":"M Auzanneau","year":"2021","unstructured":"Auzanneau M, Rosenbauer J, Maier W et al (2021) Heterogeneity of access to diabetes technology depending on area deprivation and demographics between 2016 and 2019 in Germany. J Diabetes Sci Technol 15(5):1059\u20131068. https:\/\/doi.org\/10.1177\/19322968211028608","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"6494_CR67","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2337\/cd21-0028","volume":"39","author":"S Majidi","year":"2021","unstructured":"Majidi S, Ebekozien O, Noor N et al (2021) Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D exchange quality improvement collaborative. Clinical Diabetes 39(3):278\u2013283. https:\/\/doi.org\/10.2337\/cd21-0028","journal-title":"Clinical Diabetes"},{"key":"6494_CR68","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2147\/DMSO.S416192","volume":"16","author":"RB Conway","year":"2023","unstructured":"Conway RB, Gerard Gonzalez A, Shah VN et al (2023) Racial disparities in diabetes technology adoption and their association with HbA1c and diabetic ketoacidosis. Diabetes Metab Syndr Obes 16:2295\u20132310. https:\/\/doi.org\/10.2147\/DMSO.S416192","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"6494_CR69","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/1932296821995810","volume":"15","author":"KL Fantasia","year":"2021","unstructured":"Fantasia KL, Wirunsawanya K, Lee C, Rizo I (2021) Racial disparities in diabetes technology use and outcomes in type 1 diabetes in a safety-net hospital. J Diabetes Sci Technol 15(5):1010\u20131017. https:\/\/doi.org\/10.1177\/1932296821995810","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"6494_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2337\/cd23-0052","volume":"42","author":"P Prahalad","year":"2024","unstructured":"Prahalad P, Hardison H, Odugbesan O et al (2024) Benchmarking diabetes technology use among 21 U.S. pediatric diabetes centers. Clin Diabetes 42(1):27\u201333. https:\/\/doi.org\/10.2337\/cd23-0052","journal-title":"Clin Diabetes"},{"issue":"2","key":"6494_CR71","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4103\/2249-4863.192362","volume":"5","author":"L Leung","year":"2016","unstructured":"Leung L (2016) Diabetes mellitus and the Aboriginal diabetic initiative in Canada: an update review. J Family Med Prim Care 5(2):259\u2013265. https:\/\/doi.org\/10.4103\/2249-4863.192362","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"6494_CR72","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1186\/s12913-023-10121-6","volume":"23","author":"ASY Eer","year":"2023","unstructured":"Eer ASY, Ho RCY, Hearn T et al (2023) Feasibility and acceptability of the use of flash glucose monitoring encountered by Indigenous Australians with type 2 diabetes mellitus: initial experiences from a pilot study. BMC Health Serv Res 23(1):1377. https:\/\/doi.org\/10.1186\/s12913-023-10121-6","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"6494_CR73","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40200-023-01215-3","volume":"22","author":"M Burnside","year":"2023","unstructured":"Burnside M, Haitana T, Crocket H et al (2023) Interviews with indigenous M\u0101ori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial. J Diabetes Metab Disord 22(1):861\u2013871. https:\/\/doi.org\/10.1007\/s40200-023-01215-3","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"6494_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1068\/a37168","volume":"38","author":"M Noble","year":"2006","unstructured":"Noble M, Wright G, Smith G, Dibben C (2006) Measuring multiple deprivation at the small-area level. Environ Plan A 38(1):169\u2013185. https:\/\/doi.org\/10.1068\/a37168","journal-title":"Environ Plan A"},{"issue":"8","key":"6494_CR75","doi-asserted-by":"publisher","first-page":"e15338","DOI":"10.1111\/dme.15338","volume":"41","author":"KD Barnard-Kelly","year":"2024","unstructured":"Barnard-Kelly KD, Mart\u00ednez-Brocca MA, Glatzer T, Oliver N (2024) Identifying the deficiencies of currently available CGM to improve uptake and benefit. Diabetic Med 41(8):e15338. https:\/\/doi.org\/10.1111\/dme.15338","journal-title":"Diabetic Med"},{"issue":"4","key":"6494_CR76","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/19322968211050649","volume":"16","author":"EM Everett","year":"2022","unstructured":"Everett EM, Wisk LE (2022) Relationships between socioeconomic status, insurance coverage for diabetes technology and adverse health in patients with type 1 diabetes. J Diabetes Sci Technol 16(4):825\u2013833. https:\/\/doi.org\/10.1177\/19322968211050649","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"6494_CR77","doi-asserted-by":"publisher","first-page":"e14575","DOI":"10.1111\/dme.14575","volume":"38","author":"A Addala","year":"2021","unstructured":"Addala A, Suttiratana SC, Wong JJ et al (2021) Cost considerations for adoption of diabetes technology are pervasive: a qualitative study of persons living with type 1 diabetes and their families. Diabet Med 38(10):e14575. https:\/\/doi.org\/10.1111\/dme.14575","journal-title":"Diabet Med"},{"issue":"5","key":"6494_CR78","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/19322968211006476","volume":"15","author":"A Addala","year":"2021","unstructured":"Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK (2021) Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the united states: findings from the gatekeeper study. J Diabetes Sci Technol 15(5):1027\u20131033. https:\/\/doi.org\/10.1177\/19322968211006476","journal-title":"J Diabetes Sci Technol"},{"key":"6494_CR79","doi-asserted-by":"publisher","unstructured":"Odugbesan O, Addala A, Nelson G et al (2022) Implicit racial-ethnic and insurance mediated bias to recommending diabetes technology: insights from T1D exchange multi-center pediatric and adult diabetes provider cohort. Diabetes Technol Ther 24(9). https:\/\/doi.org\/10.1089\/dia.2022.0042","DOI":"10.1089\/dia.2022.0042"},{"issue":"2","key":"6494_CR80","doi-asserted-by":"publisher","first-page":"e15015","DOI":"10.1111\/dme.15015","volume":"40","author":"SM Ng","year":"2023","unstructured":"Ng SM, Wright NP, Yardley D et al (2023) Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England. Diabet Med 40(2):e15015. https:\/\/doi.org\/10.1111\/dme.15015","journal-title":"Diabet Med"},{"issue":"1","key":"6494_CR81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S2213-8587(23)00347-9","volume":"12","author":"J Speight","year":"2024","unstructured":"Speight J, Holmes-Truscott E, Garza M et al (2024) Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations. Lancet Diabetes Endocrinol 12(1):61\u201382. https:\/\/doi.org\/10.1016\/S2213-8587(23)00347-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"6494_CR82","doi-asserted-by":"publisher","first-page":"108514","DOI":"10.1016\/j.jdiacomp.2023.108514","volume":"37","author":"A Addala","year":"2023","unstructured":"Addala A, Wong JJ, Penaranda RM et al (2023) Expanding the use of patient-reported outcomes (PROs): screening youth with type 1 diabetes from underrepresented populations. J Diabetes Complications 37(7):108514. https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108514","journal-title":"J Diabetes Complications"},{"key":"6494_CR83","doi-asserted-by":"publisher","unstructured":"Wong J, Barley R, Hanes S et al (2020) Parental perspectives: identifying profiles of parental attitudes and barriers related to diabetes device use. Diabetes Technol Ther 22(9). https:\/\/doi.org\/10.1089\/dia.2019.0492","DOI":"10.1089\/dia.2019.0492"},{"issue":"1","key":"6494_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/pedi.12939","volume":"21","author":"JJ Wong","year":"2020","unstructured":"Wong JJ, Addala A, Abujaradeh H et al (2020) Depression in context: important considerations for youth with type 1 vs type 2 diabetes. Pediatr Diabetes 21(1):135\u2013142. https:\/\/doi.org\/10.1111\/pedi.12939","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"6494_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2337\/dc21-0496","volume":"45","author":"AR Kahkoska","year":"2021","unstructured":"Kahkoska AR, Pokaprakarn T, Alexander GR et al (2021) The impact of racial and ethnic health disparities in diabetes management on clinical outcomes: a reinforcement learning analysis of health inequity among youth and young adults in the SEARCH for diabetes in youth study. Diabetes Care 45(1):108\u2013118. https:\/\/doi.org\/10.2337\/dc21-0496","journal-title":"Diabetes Care"},{"issue":"8","key":"6494_CR86","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/dia.2019.0105","volume":"21","author":"LH Messer","year":"2019","unstructured":"Messer LH, Berget C, Forlenza GP (2019) A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm. Diabetes Technol Ther 21(8):462\u2013469. https:\/\/doi.org\/10.1089\/dia.2019.0105","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"6494_CR87","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/1753-0407.13401","volume":"15","author":"JJ Wong","year":"2023","unstructured":"Wong JJ, Addala A, Hanes SJ et al (2023) DiabetesWise: an innovative approach to promoting diabetes device awareness. J Diabetes 15(7):597\u2013606. https:\/\/doi.org\/10.1111\/1753-0407.13401","journal-title":"J Diabetes"},{"issue":"3","key":"6494_CR88","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/19322968211001444","volume":"15","author":"TW Martens","year":"2021","unstructured":"Martens TW, Lima JS, Johnson EA et al (2021) Trial of a new diabetes education model: closing the gap in health disparity for people with diabetes. J Diabetes Sci Technol 15(3):568\u2013574. https:\/\/doi.org\/10.1177\/19322968211001444","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"6494_CR89","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2337\/ds20-0045","volume":"34","author":"NA Allen","year":"2021","unstructured":"Allen NA, Litchman ML, Neller S et al (2021) Couples managing type 1 diabetes using diabetes technology. Diabetes Spectr 34(4):378\u2013387. https:\/\/doi.org\/10.2337\/ds20-0045","journal-title":"Diabetes Spectr"},{"key":"6494_CR90","doi-asserted-by":"publisher","unstructured":"Allen NA, Litchman ML, Greenwood DA, Ng A, Sanchez-Birkhead A (2023) Hispanic diabetes peer facilitator training needs and connections to hispanics with type 2 diabetes. Hisp Health Care Int 15404153231175998. https:\/\/doi.org\/10.1177\/15404153231175998","DOI":"10.1177\/15404153231175998"},{"key":"6494_CR91","doi-asserted-by":"publisher","unstructured":"Goulder T, Kar P (2013) Facillitating diabetes care - a community approach. BMJ Qual Improv Report 2(1). https:\/\/doi.org\/10.1136\/bmjquality.u201112.w708","DOI":"10.1136\/bmjquality.u201112.w708"},{"issue":"6","key":"6494_CR92","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jcjd.2022.06.002","volume":"46","author":"Z Jones","year":"2022","unstructured":"Jones Z, Akerman J, Bajurny V, Gaudreau A, Rochon P, Mason R (2022) Exploring the lived experience of diabetes through an intersectional lens: a qualitative study of adults with type 1 and type 2 diabetes. Can J Diabetes 46(6):620\u2013627. https:\/\/doi.org\/10.1016\/j.jcjd.2022.06.002","journal-title":"Can J Diabetes"},{"issue":"4","key":"6494_CR93","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2337\/ds21-0067","volume":"35","author":"ML Litchman","year":"2022","unstructured":"Litchman ML, Allen NA, Sanchez-Birkhead A et al (2022) Continuous glucose monitoring plus an online peer support community reinforces healthy behaviors in hispanic adults with type 2 diabetes. Diabetes Spectr 35(4):452\u2013460. https:\/\/doi.org\/10.2337\/ds21-0067","journal-title":"Diabetes Spectr"},{"issue":"4","key":"6494_CR94","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1210\/clinem\/dgab859","volume":"107","author":"P Prahalad","year":"2021","unstructured":"Prahalad P, Ding VY, Zaharieva DP et al (2021) Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: pilot 4T study. J Clin Endocrinol Metab 107(4):998\u20131008. https:\/\/doi.org\/10.1210\/clinem\/dgab859","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6494_CR95","doi-asserted-by":"publisher","first-page":"e238881","DOI":"10.1001\/jamanetworkopen.2023.8881","volume":"6","author":"A Addala","year":"2023","unstructured":"Addala A, Ding V, Zaharieva DP et al (2023) Disparities in hemoglobin A1c levels in the first year after diagnosis among youths with type 1 diabetes offered continuous glucose monitoring. JAMA Netw Open 6(4):e238881. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8881","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6494_CR96","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/1753-0407.13235","volume":"14","author":"O Ebekozien","year":"2022","unstructured":"Ebekozien O, Mungmode A, Odugbesan O et al (2022) Addressing type 1 diabetes health inequities in the United States: approaches from the T1D Exchange QI Collaborative. J Diabetes 14(1):79\u201382. https:\/\/doi.org\/10.1111\/1753-0407.13235","journal-title":"J Diabetes"},{"issue":"1","key":"6494_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2337\/cd23-0050","volume":"42","author":"O Odugbesan","year":"2023","unstructured":"Odugbesan O, Mungmode A, Rioles N et al (2023) Increasing continuous glucose monitoring use for non-hispanic black and hispanic people with type 1 diabetes: results from the T1D exchange quality improvement collaborative equity study. Clinical Diabetes 42(1):40\u201348. https:\/\/doi.org\/10.2337\/cd23-0050","journal-title":"Clinical Diabetes"},{"issue":"6","key":"6494_CR98","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.eprac.2024.04.001","volume":"30","author":"D Steenkamp","year":"2024","unstructured":"Steenkamp D, Brouillard E, Aia C et al (2024) Reducing inequity in the use of automated insulin delivery systems by adults with type 1 diabetes: key learnings from a safety net diabetes clinic program. Endocr Pract 30(6):558\u2013563. https:\/\/doi.org\/10.1016\/j.eprac.2024.04.001","journal-title":"Endocr Pract"},{"issue":"2","key":"6494_CR99","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/ds21-0091","volume":"35","author":"ML Litchman","year":"2022","unstructured":"Litchman ML, Moreland C, Fagerlin A, Kushalnagar P (2022) Limited diabetes education and resources in American sign language. Diabetes Spectr 35(2):134\u2013135. https:\/\/doi.org\/10.2337\/ds21-0091","journal-title":"Diabetes Spectr"},{"issue":"3","key":"6494_CR100","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/dom.14273","volume":"23","author":"L Leelarathna","year":"2021","unstructured":"Leelarathna L, Choudhary P, Wilmot EG et al (2021) Hybrid closed-loop therapy: where are we in 2021? Diabetes Obes Metab 23(3):655\u2013660. https:\/\/doi.org\/10.1111\/dom.14273","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"6494_CR101","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/dia.2021.0334","volume":"24","author":"Z Ju","year":"2022","unstructured":"Ju Z, Piarulli A, Bielick L, Marschall S, Brouillard E, Steenkamp D (2022) Advanced diabetes technology remains underutilized in underserved populations: early hybrid closed-loop system experience at an academic safety net hospital. Diabetes Technol Ther 24(2):143\u2013147. https:\/\/doi.org\/10.1089\/dia.2021.0334","journal-title":"Diabetes Technol Ther"},{"key":"6494_CR102","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.lanwpc.2022.100644","volume":"31","author":"MJ Burnside","year":"2023","unstructured":"Burnside MJ, Williman JA, Davies HM et al (2023) Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand. Lancet Reg Health West Pac 31:100644. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100644","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"6494_CR103","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/dc21-1666","volume":"45","author":"SR Johnson","year":"2022","unstructured":"Johnson SR, Holmes-Walker DJ, Chee M et al (2022) Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study. Diabetes Care 45(2):391\u2013397. https:\/\/doi.org\/10.2337\/dc21-1666","journal-title":"Diabetes Care"},{"issue":"2","key":"6494_CR104","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/ds20-0041","volume":"34","author":"A Addala","year":"2020","unstructured":"Addala A, Chan RY, Vargas J, Weigensberg MJ (2020) Global well-being is associated with A1C and frequency of self-monitoring of blood glucose in predominately Latinx youth and young adults with type 1 diabetes. Diabetes Spectrum 34(2):202\u2013208. https:\/\/doi.org\/10.2337\/ds20-0041","journal-title":"Diabetes Spectrum"},{"issue":"4","key":"6494_CR105","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dc17-2233","volume":"41","author":"JP Reis","year":"2018","unstructured":"Reis JP, Allen NB, Bancks MP et al (2018) Duration of diabetes and prediabetes during adulthood and subclinical atherosclerosis and cardiac dysfunction in middle age: the CARDIA study. Diabetes Care 41(4):731\u2013738. https:\/\/doi.org\/10.2337\/dc17-2233","journal-title":"Diabetes Care"},{"issue":"9","key":"6494_CR106","doi-asserted-by":"publisher","first-page":"107605","DOI":"10.1016\/j.jdiacomp.2020.107605","volume":"34","author":"A Fujiyoshi","year":"2020","unstructured":"Fujiyoshi A, Suri MFK, Alonso A et al (2020) Hyperglycemia, duration of diabetes, and intracranial atherosclerotic stenosis by magnetic resonance angiography: the ARIC-NCS study. J Diabetes Complicat 34(9):107605. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107605","journal-title":"J Diabetes Complicat"},{"issue":"9","key":"6494_CR107","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00125-024-06205-5","volume":"67","author":"M Phillip","year":"2024","unstructured":"Phillip M, Achenbach P, Addala A et al (2024) Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetologia 67(9):1731\u20131759. https:\/\/doi.org\/10.1007\/s00125-024-06205-5","journal-title":"Diabetologia"},{"issue":"8","key":"6494_CR108","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","volume":"10","author":"MJ Redondo","year":"2022","unstructured":"Redondo MJ, Gignoux CR, Dabelea D et al (2022) Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol 10(8):597\u2013608. https:\/\/doi.org\/10.1016\/S2213-8587(22)00159-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"6494_CR109","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc18-0087","volume":"41","author":"MJ Redondo","year":"2018","unstructured":"Redondo MJ, Geyer S, Steck AK et al (2018) A Type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Dia Care 41(9):1887\u20131894. https:\/\/doi.org\/10.2337\/dc18-0087","journal-title":"Dia Care"},{"issue":"3","key":"6494_CR110","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1573399813666170502105402","volume":"14","author":"M Tosur","year":"2018","unstructured":"Tosur M, Redondo MJ (2018) Heterogeneity of type 1 diabetes: the effect of ethnicity. Curr Diabetes Rev 14(3):266\u2013272. https:\/\/doi.org\/10.2174\/1573399813666170502105402","journal-title":"Curr Diabetes Rev"},{"issue":"15","key":"6494_CR111","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","volume":"376","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis EJ, Lawrence JM, Dabelea D et al (2017) Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012. N Engl J Med 376(15):1419\u20131429. https:\/\/doi.org\/10.1056\/NEJMoa1610187","journal-title":"N Engl J Med"},{"key":"6494_CR112","doi-asserted-by":"publisher","first-page":"109083","DOI":"10.1016\/j.diabres.2021.109083","volume":"183","author":"GD Ogle","year":"2022","unstructured":"Ogle GD, James S, Dabelea D et al (2022) Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition. Diabetes Res Clin Pract 183:109083. https:\/\/doi.org\/10.1016\/j.diabres.2021.109083","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6494_CR113","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s40001-023-01563-z","volume":"28","author":"J Melin","year":"2023","unstructured":"Melin J, Lynch KF, Lundgren M, Aronsson CA, Larsson HE, Johnson SB (2023) Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance: the TEDDY study. Eur J Med Res 28(1):592. https:\/\/doi.org\/10.1186\/s40001-023-01563-z","journal-title":"Eur J Med Res"},{"issue":"1","key":"6494_CR114","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12902-021-00929-w","volume":"22","author":"J Melin","year":"2022","unstructured":"Melin J, Lynch KF, Lundgren M et al (2022) Is staff consistency important to parents\u2019 satisfaction in a longitudinal study of children at risk for type 1 diabetes: the TEDDY study. BMC Endocr Disord 22(1):19. https:\/\/doi.org\/10.1186\/s12902-021-00929-w","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"6494_CR115","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2337\/dc18-2282","volume":"42","author":"JP Krischer","year":"2019","unstructured":"Krischer JP, Liu X, Vehik K et al (2019) Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report. Diabetes Care 42(6):1051\u20131060. https:\/\/doi.org\/10.2337\/dc18-2282","journal-title":"Diabetes Care"},{"issue":"5","key":"6494_CR116","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/pedi.13173","volume":"22","author":"LB Smith","year":"2021","unstructured":"Smith LB, Lynch KF, Driscoll KA, Johnson SB, TEDDY Study Group (2021) Parental monitoring for type 1 diabetes in genetically at-risk young children: the TEDDY study. Pediatr Diabetes 22(5):717\u2013728. https:\/\/doi.org\/10.1111\/pedi.13173","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"6494_CR117","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R et al (2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27(10):1361\u20131367. https:\/\/doi.org\/10.1007\/s11606-012-2077-6","journal-title":"J Gen Intern Med"},{"issue":"5","key":"6494_CR118","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jcjd.2020.03.009","volume":"44","author":"S Davis","year":"2020","unstructured":"Davis S, MacKay L (2020) Moving beyond the rhetoric of shared decision-making: designing personal health record technology with young adults with type 1 diabetes. Can J Diabetes 44(5):434\u2013441. https:\/\/doi.org\/10.1016\/j.jcjd.2020.03.009","journal-title":"Can J Diabetes"},{"issue":"6","key":"6494_CR119","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/dme.13143","volume":"33","author":"V Serrano","year":"2016","unstructured":"Serrano V, Rodriguez-Gutierrez R, Hargraves I, Gionfriddo MR, Tamhane S, Montori VM (2016) Shared decision-making in the care of individuals with diabetes. Diabetic Med 33(6):742\u2013751. https:\/\/doi.org\/10.1111\/dme.13143","journal-title":"Diabetic Med"},{"issue":"4","key":"6494_CR120","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bmjebm-2022-112068","volume":"28","author":"VM Montori","year":"2023","unstructured":"Montori VM, Ruissen MM, Hargraves IG, Brito JP, Kunneman M (2023) Shared decision-making as a method of care. BMJ Evid Based Med 28(4):213\u2013217. https:\/\/doi.org\/10.1136\/bmjebm-2022-112068","journal-title":"BMJ Evid Based Med"},{"issue":"11","key":"6494_CR121","doi-asserted-by":"publisher","first-page":"e14937","DOI":"10.1111\/dme.14937","volume":"39","author":"RE Brown","year":"2022","unstructured":"Brown RE, Chu L, Norman GJ, Abitbol A (2022) Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: a retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D). Diabet Med 39(11):e14937. https:\/\/doi.org\/10.1111\/dme.14937","journal-title":"Diabet Med"},{"issue":"8","key":"6494_CR122","doi-asserted-by":"publisher","first-page":"e0160971","DOI":"10.1371\/journal.pone.0160971","volume":"11","author":"B Bohn","year":"2016","unstructured":"Bohn B, Karges B, Vogel C et al (2016) 20 years of pediatric benchmarking in germany and austria: age-dependent analysis of longitudinal follow-up in 63,967 children and adolescents with type 1 diabetes. PLoS ONE 11(8):e016097, 1. https:\/\/doi.org\/10.1371\/journal.pone.0160971","journal-title":"PLoS ONE"},{"issue":"8","key":"6494_CR123","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jpedsurg.2017.08.023","volume":"53","author":"EC Hamilton","year":"2018","unstructured":"Hamilton EC, Saiyed F, Miller CC et al (2018) The digital divide in adoption and use of mobile health technology among caregivers of pediatric surgery patients. J Pediatr Surg 53(8):1478\u20131493. https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.08.023","journal-title":"J Pediatr Surg"},{"key":"6494_CR124","unstructured":"Chandra S, Fazlullah A, Hill H et al (2020) Connect all students: How states and school districts can close the digital divide. Common Sense Media, San Francisco, CA, USA"},{"key":"6494_CR125","unstructured":"North Carolina Department of Information Technology (NCDIT) (2021) What Is the Digital Divide? Available from: https:\/\/www.ncbroadband.gov\/digital-divide\/what-digital-divide. Accessed 9 Dec 2024"},{"issue":"22","key":"6494_CR126","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1056\/NEJMe2303219","volume":"389","author":"SH Friend","year":"2023","unstructured":"Friend SH, Ginsburg GS, Picard RW (2023) Wearable digital health technology. N Engl J Med 389(22):2100\u20132101. https:\/\/doi.org\/10.1056\/NEJMe2303219","journal-title":"N Engl J Med"},{"key":"6494_CR127","unstructured":"Silver L, Vogels EA, Mordecai M, Cha J, Rasmussen R, Raine L (2019) 1. Non-mobile phone users: What hinders their access? Available from: https:\/\/www.pewresearch.org\/internet\/2019\/11\/20\/non-mobile-phone-users-what-hinders-their-access\/. Accessed 7 Dec 2024"},{"key":"6494_CR128","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.procs.2018.10.021","volume":"138","author":"R Custodio","year":"2018","unstructured":"Custodio R, Victorino JN, Justina Estuar MR (2018) The efficacy of an EMR-enabled text messaging system to the expanded health beliefs, diabetes care profile and HbA1c of diabetes mellitus patients. Procedia Computer Science 138:143\u2013152. https:\/\/doi.org\/10.1016\/j.procs.2018.10.021","journal-title":"Procedia Computer Science"},{"issue":"10","key":"6494_CR129","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jamia\/ocz091","volume":"26","author":"LS Mayberry","year":"2019","unstructured":"Mayberry LS, Bergner EM, Harper KJ, Laing S, Berg CA (2019) Text messaging to engage friends\/family in diabetes self-management support: acceptability and potential to address disparities. J Am Med Inform Assoc 26(10):1099\u20131108. https:\/\/doi.org\/10.1093\/jamia\/ocz091","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"6494_CR130","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jamiaopen\/ooad049","volume":"6","author":"BA Sisk","year":"2023","unstructured":"Sisk BA, Lin S, Balls-Berry JJE, Servin AE, Mack JW (2023) Identifying contributors to disparities in patient access of online medical records: examining the role of clinician encouragement. JAMIA Open 6(3):49. https:\/\/doi.org\/10.1093\/jamiaopen\/ooad049","journal-title":"JAMIA Open"},{"issue":"6","key":"6494_CR131","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/tmj.2019.0035","volume":"26","author":"R Xu","year":"2020","unstructured":"Xu R, Xing M, Javaherian K, Peters R, Ross W, Bernal-Mizrachi C (2020) Improving HbA1c with glucose self-monitoring in diabetic patients with EpxDiabetes, a phone call and text message-based telemedicine platform: a randomized controlled trial. Telemed e-Health 26(6):784\u2013793. https:\/\/doi.org\/10.1089\/tmj.2019.0035","journal-title":"Telemed e-Health"},{"issue":"7","key":"6494_CR132","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/s41591-024-02975-y","volume":"30","author":"P Prahalad","year":"2024","unstructured":"Prahalad P, Scheinker D, Desai M et al (2024) Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes. Nat Med 30(7):2067\u20132075. https:\/\/doi.org\/10.1038\/s41591-024-02975-y","journal-title":"Nat Med"},{"key":"6494_CR133","doi-asserted-by":"publisher","first-page":"109777","DOI":"10.1016\/j.diabres.2022.109777","volume":"185","author":"A Sathyanarayanan","year":"2022","unstructured":"Sathyanarayanan A, Crabtree T, Choudhary P et al (2022) Delivering evidence-based interventions for type 1 diabetes in the virtual world - A review of UK practice during the SARS-CoV-2 pandemic. Diabetes Res Clin Pract 185:109777. https:\/\/doi.org\/10.1016\/j.diabres.2022.109777","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6494_CR134","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/tmj.2019.0280","volume":"27","author":"JA Andersen","year":"2021","unstructured":"Andersen JA, Scoggins D, Michaud T, Wan N, Wen M, Su D (2021) Racial disparities in diabetes management outcomes: evidence from a remote patient monitoring program for type 2 diabetic patients. Telemed e-Health 27(1):55\u201361. https:\/\/doi.org\/10.1089\/tmj.2019.0280","journal-title":"Telemed e-Health"},{"key":"6494_CR135","doi-asserted-by":"publisher","first-page":"110809","DOI":"10.1016\/j.diabres.2023.110809","volume":"202","author":"A Chobot","year":"2023","unstructured":"Chobot A, Lanzinger S, Alkandari H et al (2023) Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic. Diabetes Res Clin Pract 202:110809. https:\/\/doi.org\/10.1016\/j.diabres.2023.110809","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6494_CR136","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S2213-8587(24)00279-1","volume":"13","author":"AT Zimmermann","year":"2024","unstructured":"Zimmermann AT, Lanzinger S, Kummernes SJ et al (2024) Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013\u201322): a longitudinal analysis of data from paediatric diabetes registries. Lancet Diabetes Endocrinol 13(1):47\u201356. https:\/\/doi.org\/10.1016\/S2213-8587(24)00279-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"6494_CR137","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/dom.13937","volume":"22","author":"JH Pettus","year":"2020","unstructured":"Pettus JH, Zhou FL, Shepherd L et al (2020) Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record database. Diabetes Obes Metab 22(4):622\u2013630. https:\/\/doi.org\/10.1111\/dom.13937","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"6494_CR138","doi-asserted-by":"publisher","first-page":"e0211551","DOI":"10.1371\/journal.pone.0211551","volume":"14","author":"S Dandge","year":"2019","unstructured":"Dandge S, Jeemon P, Reddy PS (2019) Technology enabled non-physician health workers extending telemedicine to rural homes to control hypertension and diabetes (TETRA): A pre-post demonstration project in Telangana, India. PLoS One 14(2):e0211551. https:\/\/doi.org\/10.1371\/journal.pone.0211551","journal-title":"PLoS One"},{"issue":"1","key":"6494_CR139","doi-asserted-by":"publisher","first-page":"1517930","DOI":"10.1080\/16549716.2018.1517930","volume":"11","author":"D Jindal","year":"2018","unstructured":"Jindal D, Gupta P, Jha D et al (2018) Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings. Glob Health Action 11(1):1517930. https:\/\/doi.org\/10.1080\/16549716.2018.1517930","journal-title":"Glob Health Action"},{"issue":"6","key":"6494_CR140","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/193229681200600614","volume":"6","author":"V Mohan","year":"2012","unstructured":"Mohan V, Deepa M, Pradeepa R et al (2012) Prevention of diabetes in rural India with a telemedicine intervention. J Diabetes Sci Technol 6(6):1355\u20131364. https:\/\/doi.org\/10.1177\/193229681200600614","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"6494_CR141","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jama.2018.1150","volume":"319","author":"I Papanicolas","year":"2018","unstructured":"Papanicolas I, Woskie LR, Jha AK (2018) Health care spending in the United States and other high-income countries. JAMA 319(10):1024. https:\/\/doi.org\/10.1001\/jama.2018.1150","journal-title":"JAMA"},{"issue":"1","key":"6494_CR142","doi-asserted-by":"publisher","first-page":"e42483","DOI":"10.2196\/42483","volume":"25","author":"LF Nakayama","year":"2023","unstructured":"Nakayama LF, Binotti WW, Woite NL et al (2023) The digital divide in Brazil and barriers to telehealth and equal digital health care: analysis of internet access using publicly available data. J Med Int Res 25(1):e4248310. https:\/\/doi.org\/10.2196\/42483","journal-title":"J Med Int Res"},{"key":"6494_CR143","doi-asserted-by":"publisher","first-page":"1418627","DOI":"10.3389\/fpubh.2024.1418627","volume":"12","author":"EM Spaulding","year":"2024","unstructured":"Spaulding EM, Miller HN, Metlock FE et al (2024) Leveraging community Wi-Fi and spaces for digital health use. Front Public Health 12:1418627. https:\/\/doi.org\/10.3389\/fpubh.2024.1418627","journal-title":"Front Public Health"},{"key":"6494_CR144","unstructured":"Carlson E, Goss J (2016) The State of the Urban\/Rural Digital Divide. Available from: https:\/\/www.ntia.gov\/blog\/2016\/state-urbanrural-digital-divide. Accessed 7 Dec 2024"},{"issue":"7","key":"6494_CR145","doi-asserted-by":"publisher","first-page":"e37120","DOI":"10.2196\/37120","volume":"24","author":"K Braune","year":"2022","unstructured":"Braune K, Krug N, Knoll C et al (2022) Emotional and physical health impact in children and adolescents and their caregivers using open-source automated insulin delivery: qualitative analysis of lived experiences. J Med Internet Res 24(7):e37120. https:\/\/doi.org\/10.2196\/37120","journal-title":"J Med Internet Res"},{"key":"6494_CR146","doi-asserted-by":"publisher","first-page":"876511","DOI":"10.3389\/fcdhc.2022.876511","volume":"3","author":"A Huhndt","year":"2022","unstructured":"Huhndt A, Chen Y, O\u2019Donnell S et al (2022) Barriers to uptake of open-source automated insulin delivery systems: analysis of socioeconomic factors and perceived challenges of caregivers of children and adolescents with type 1 diabetes from the OPEN survey. Front Clin Diabetes Healthc 3:876511. https:\/\/doi.org\/10.3389\/fcdhc.2022.876511","journal-title":"Front Clin Diabetes Healthc"},{"key":"6494_CR147","doi-asserted-by":"publisher","first-page":"110235","DOI":"10.1016\/j.diabres.2022.110235","volume":"197","author":"S O\u2019Donnell","year":"2023","unstructured":"O\u2019Donnell S, Cooper D, Chen Y et al (2023) Barriers to uptake of open-source automated insulin delivery systems: analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey. Diabetes Res Clin Pract 197:110235. https:\/\/doi.org\/10.1016\/j.diabres.2022.110235","journal-title":"Diabetes Res Clin Pract"},{"key":"6494_CR148","doi-asserted-by":"publisher","first-page":"1066521","DOI":"10.3389\/fendo.2022.1066521","volume":"13","author":"A Addala","year":"2022","unstructured":"Addala A, Filipp SL, Figg LE et al (2022) Tele-education model for primary care providers to advance diabetes equity: Findings from Project ECHO Diabetes. Front Endocrinol (Lausanne) 13:1066521. https:\/\/doi.org\/10.3389\/fendo.2022.1066521","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"6494_CR149","doi-asserted-by":"publisher","first-page":"e002262","DOI":"10.1136\/bmjdrc-2021-002262","volume":"9","author":"AF Walker","year":"2021","unstructured":"Walker AF, Cuttriss N, Haller MJ et al (2021) Democratizing type 1 diabetes specialty care in the primary care setting to reduce health disparities: project extension for community healthcare outcomes (ECHO) T1D. BMJ Open Diabetes Res Care 9(1):e002262. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002262","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"6494_CR150","doi-asserted-by":"publisher","first-page":"e004229","DOI":"10.1136\/bmjdrc-2024-004229","volume":"12","author":"AF Walker","year":"2024","unstructured":"Walker AF, Haller MJ, Addala A et al (2024) Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts. BMJ Open Diabetes Res Care 12(4):e004229. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004229","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"6494_CR151","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jadohealth.2018.03.010","volume":"62","author":"CR Harper","year":"2018","unstructured":"Harper CR, Steiner RJ, Brookmeyer KA (2018) Using the social-ecological model to improve access to care for adolescents and young adults. J Adolesc Health 62(6):641\u2013642. https:\/\/doi.org\/10.1016\/j.jadohealth.2018.03.010","journal-title":"J Adolesc Health"},{"issue":"1","key":"6494_CR152","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/dci20-0048","volume":"44","author":"TH Lipman","year":"2021","unstructured":"Lipman TH, Hawkes CP (2021) Racial and socioeconomic disparities in pediatric type 1 diabetes: time for a paradigm shift in approach. Diabetes Care 44(1):14\u201316. https:\/\/doi.org\/10.2337\/dci20-0048","journal-title":"Diabetes Care"},{"issue":"1","key":"6494_CR153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2337\/cd23-0057","volume":"42","author":"E Ospelt","year":"2024","unstructured":"Ospelt E, Hardison H, Rioles N et al (2024) Understanding providers\u2019 readiness and attitudes toward autoantibody screening: a mixed-methods study. Clin Diabetes 42(1):17\u201326. https:\/\/doi.org\/10.2337\/cd23-0057","journal-title":"Clin Diabetes"},{"key":"6494_CR154","unstructured":"Milken Institute (2021) Type 1 diabetes autoantibody screening: a roadmap for pediatric policy implementation. Available from: https:\/\/milkeninstitute.org\/content-hub\/research-and-reports\/reports\/type-1-diabetes-autoantibody-screening-roadmap-pediatric-policy-implementation. Accessed 4 Dec 2024"},{"issue":"6S","key":"6494_CR155","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.12788\/jfp.0223","volume":"70","author":"A Peters","year":"2021","unstructured":"Peters A (2021) Screening for autoantibodies in type 1 diabetes: a call to action. J Fam Pract 70(6S):S47\u2013S52. https:\/\/doi.org\/10.12788\/jfp.0223","journal-title":"J Fam Pract"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06494-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:02:31Z","timestamp":1784671351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06494-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":155,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6494"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06494-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors would like to thank D. Garfias Silva (Division of Pediatric Endocrinology, Stanford University) for his support in generating and developing Figs\n                      \n                      and\n                      \n                      .","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This publication is unfunded work; AA\u2019s time is supported by NIDDK (5K23DK131342).","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"OE has received an honorarium from Sanofi. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"AA and OE conceived the manuscript outline. AA and MIA conducted the literature review. AA wrote the manuscript with critical edits from LEF. All authors reviewed and edited the manuscript and approved the final version for publication.","order":4,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}